Cyanohydridoborate anion as a selective reducing agent

RF Borch, MD Bernstein, HD Durst - Journal of the American …, 1971 - ACS Publications
Sodium cyanohydridoborate (NaBH3CN) reduces a wide variety of organic functional groups
with remarkable selectivity. The reduction of aldehydes and ketones is pH dependent, the …

[PDF][PDF] Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival-a report from the Children's Oncology Group

…, MD Krailo, JH Healey, ML Bernstein… - Journal of clinical …, 2008 - academia.edu
Purpose To compare three-drug chemotherapy with cisplatin, doxorubicin, and methotrexate
with four-drug chemotherapy with cisplatin, doxorubicin, methotrexate, and ifosfamide for …

[PDF][PDF] Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens

…, R Russell, J Bayani, R Head, M Lee, M Bernstein… - Cell stem cell, 2009 - cell.com
Human brain tumors appear to have a hierarchical cellular organization suggestive of a
stem cell foundation. In vitro expansion of the putative cancer stem cells as stable cell lines …

[PDF][PDF] Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate

…, ES Kleinerman, D Betcher, ML Bernstein… - Journal of clinical …, 2005 - researchgate.net
Purpose To determine whether the addition of ifosfamide and/or muramyl tripeptide (MTP)
encapsulated in liposomes to cisplatin, doxorubicin, and high-dose methotrexate (HDMTX) …

Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project

…, AM Morris, A Asher, KO Lillehei, M Bernstein… - Journal of …, 2003 - thejns.org
Object. The Glioma Outcomes Project represents a contemporary analysis of the management
of malignant (Grade III and Grade IV/GBM) gliomas in North America. This observational …

Neurological manifestations of intracranial dural arteriovenous malformations

…, K Ter Brugge, A Tolia, M Hurth, M Bernstein - Journal of …, 1986 - thejns.org
✓ The authors describe their experience with four cases of dural arteriovenous malformation
(AVM) which led them to analyze the clinical aspects of these lesions in an attempt to …

[PDF][PDF] Ewing sarcoma: current management and future approaches through collaboration

…, L Hjorth, I Judson, R Luksch, ML Bernstein… - J Clin …, 2015 - researchgate.net
Ewing sarcoma (ES) is an aggressive sarcoma of bone and soft tissue occurring at any age
with a peak incidence in adolescents and young adults. The treatment of ES relies on a …

Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an …

…, S Smeland, SS Bielack, M Bernstein… - The Lancet …, 2016 - thelancet.com
Background We designed the EURAMOS-1 trial to investigate whether intensified postoperative
chemotherapy for patients whose tumour showed a poor response to preoperative …

Ewing's sarcoma family of tumors: current management

M Bernstein, H Kovar, M Paulussen, RL Randall… - The …, 2006 - academic.oup.com
Mark Bernstein , Mark BernsteinMark Bernstein, Heinrich Kovar, Michael Paulussen, R.
Lor Randall, Andreas Schuck, Lisa A. Teot, Herbert Juergensg, Ewing's Sarcoma Family of …

[HTML][HTML] Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort

S Smeland, SS Bielack, J Whelan, M Bernstein… - European journal of …, 2019 - Elsevier
Background High-grade osteosarcoma is a primary malignant bone tumour mainly affecting
children and young adults. The European and American Osteosarcoma Study (EURAMOS)-…